A detailed history of 55 I, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, 55 I, LLC holds 31,569 shares of ABBV stock, worth $5.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
31,569
Previous 10,324 205.78%
Holding current value
$5.3 Million
Previous $1.58 Million 167.99%
% of portfolio
0.12%
Previous 0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2.85 Million - $3.27 Million
21,245 Added 205.78%
31,569 $4.24 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $468,733 - $595,913
3,406 Added 49.23%
10,324 $1.58 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $89,218 - $110,695
676 Added 10.83%
6,918 $1.12 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $450,131 - $569,546
-4,190 Reduced 40.16%
6,242 $844,000
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $554,982 - $629,988
5,216 Added 100.0%
10,432 $1.13 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $144,137 - $160,577
1,370 Added 35.62%
5,216 $588,000
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $393,445 - $433,136
3,846 New
3,846 $416,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track 55 I, LLC Portfolio

Follow 55 I, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 55 I, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 55 I, LLC with notifications on news.